Century Therapeutics Inc (NASDAQ: IPSC) is -76.97% lower on its value in year-to-date trading and has touched a low of $0.34 and a high of $3.29 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IPSC stock was last observed hovering at around $0.56 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.56, the stock is -4.28% and -0.39% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing 0.02% at the moment leaves the stock -39.93% off its SMA200. IPSC registered -45.04% loss for a year compared to 6-month loss of -44.49%.
The stock witnessed a -2.63% gain in the last 1 month and extending the period to 3 months gives it a 18.18%, and is -2.20% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.37% over the week and 6.30% over the month.
Century Therapeutics Inc (IPSC) has around 150 employees, a market worth around $47.83M and $114.90M in sales. Profit margin for the company is -19.10%. Distance from 52-week low is 62.40% and -83.13% from its 52-week high. The company has generated returns on investments over the last 12 months (-7.61%).
The EPS is expected to grow by 82.97% this year
The shares outstanding are 86.15M, and float is at 40.60M with Short Float at 5.70%.
The top institutional shareholder in the company is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC with over 5.41 million shares valued at $13.8 million. The investor’s holdings represent 8.6848 of the IPSC Shares outstanding. As of 2024-06-30, the second largest holder is VR ADVISER, LLC with 5.39 million shares valued at $13.74 million to account for 8.651 of the shares outstanding. The other top investors are CASDIN CAPITAL, LLC which holds 5.19 million shares representing 8.3319 and valued at over $13.24 million, while BOXER CAPITAL, LLC holds 7.8682 of the shares totaling 4.9 million with a market value of $12.5 million.
Century Therapeutics Inc (IPSC) Insider Activity
The most recent transaction is an insider sale by Carr Douglas, the company’s SVP Finance & Operations. SEC filings show that Carr Douglas sold 4,904 shares of the company’s common stock on Jun 09 ’25 at a price of $0.62 per share for a total of $3050.0. Following the sale, the insider now owns 0.41 million shares.
Century Therapeutics Inc disclosed in a document filed with the SEC on Jun 09 ’25 that Farid Adrienne (Chief Operations Officer) sold a total of 552 shares of the company’s common stock. The trade occurred on Jun 09 ’25 and was made at $0.62 per share for $343.0. Following the transaction, the insider now directly holds 0.25 million shares of the IPSC stock.
Still, SEC filings show that on Jun 09 ’25, Pfeiffenberger Brent (President and CEO) disposed off 475 shares at an average price of $0.62 for $295.0. The insider now directly holds 1,681,783 shares of Century Therapeutics Inc (IPSC).
